Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:focusesOn |
influenza vaccines
|
| gptkbp:foundedIn |
1983
|
| gptkbp:founder |
gptkb:Daniel_Adams
gptkb:Leonard_A._Smith gptkb:Manon_Cox |
| gptkbp:headquartersLocation |
gptkb:Meriden,_Connecticut,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Protein Sciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Flublok
|
| gptkbp:platform |
baculovirus expression system
|
| gptkbp:specializesIn |
vaccine development
recombinant protein production |
| gptkbp:website |
https://www.proteinsciences.com/
|
| gptkbp:bfsParent |
gptkb:Sanofi-Aventis
|
| gptkbp:bfsLayer |
6
|